High-Purity 3-[3-(Piperidin-1-ylmethyl)phenoxy]propan-1-amine: Your Key Pharmaceutical Intermediate Supplier

Discover a crucial building block for your API synthesis. We are a leading manufacturer and supplier of 3-[3-(piperidin-1-ylmethyl)phenoxy]propan-1-amine (CAS: 73278-98-5), ensuring exceptional purity and reliability for your pharmaceutical development needs. Request a quote and sample today!

Get a Quote & Sample

Advantages of Sourcing Our Pharmaceutical Intermediates

Exceptional Purity and Quality

Our 3-[3-(piperidin-1-ylmethyl)phenoxy]propan-1-amine (CAS: 73278-98-5) meets stringent purity standards (95%min), ensuring optimal performance in your API synthesis, a key factor for R&D scientists and procurement managers.

Reliable Supply and Manufacturer Support

As a leading supplier and manufacturer, we guarantee a stable supply of this vital pharmaceutical intermediate. Benefit from our expertise in custom synthesis and responsive customer service to meet your bulk purchase needs.

Cost-Effective Solutions

We offer competitive pricing for high-quality pharmaceutical intermediates, providing a cost-effective solution for your drug development and manufacturing processes. Secure your supply of this essential compound at an attractive price.

Key Applications for Pharmaceutical Intermediates

API Synthesis

Utilize 3-[3-(piperidin-1-ylmethyl)phenoxy]propan-1-amine as a critical building block in the synthesis of Active Pharmaceutical Ingredients (APIs), crucial for drug manufacturing.

Pharmaceutical R&D

Essential for research and development activities, enabling scientists to explore new drug candidates and optimize synthesis pathways for pharmaceutical innovation.

Custom Synthesis Projects

We offer custom synthesis services to meet specific project requirements for this intermediate, ensuring you get precisely what you need for your unique applications.

Rosartidine Production

This intermediate is specifically used in the production of Rosartidine, a key application that highlights its importance in targeted pharmaceutical development.